| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0075 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |